I think part of the problem right now is lack of consistent daily volume. Further news might change that and with more volume should come more market interest. That can have a positive feedback on itself.
Canacord's research note target released earlier this month of $5.60 is an attractive near term target offering 64% gains from here.
Ann: $250K Convertible Note Drawdown to Fund Expansion, page-87
Add SPA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $10.36M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 526315 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.2¢ | 477916 | 4 |
View Market Depth
| Last trade - 16.13pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
2.1¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 2.1¢ | 2.1¢ | 2.1¢ | 20000 | ||
| Last updated 10.59am 10/05/2024 ? | |||||
| SPA (ASX) Chart |
Day chart unavailable